Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Breast milk is a natural biological fluid produced by the mammary glands of lactating humans. In the context of the Karabuk University clinical trial (NCT04259320), it was evaluated as a topical intervention for the prevention of nipple cracks and pain in primiparous breastfeeding mothers. The intervention involves applying a few drops of the mother's own expressed milk to the nipple and areola after breastfeeding. Breast milk contains various bioactive components, including epidermal growth factor (EGF), transforming growth factor-beta (TGF-β), and immunological factors, which are thought to promote wound healing and provide antimicrobial protection. While traditionally recommended by the World Health Organization for nipple care, the Karabuk University study found it to be less effective than a beeswax-containing barrier.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on breast milk.